TrianglePUBLICATIONS · 32468956
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2020 Jul 20
- First author
- Rudin CM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Rudin CM
- type
- Author
- name
- Awad MM
- type
- Author
- name
- Navarro A
- type
- Author
- name
- Gottfried M
- type
- Author
- name
- Peters S
- type
- Author
- name
- Csőszi T
- type
- Author
- name
- Cheema PK
- type
- Author
- name
- Rodriguez-Abreu D
- type
- Author
- name
- Wollner M
- type
- Author
- name
- Yang JC
- type
- Author
- name
- Mazieres J
- type
- Author
- name
- Orlandi FJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Rudin CM
- type
- Author
- name
- Awad MM
- type
- Author
- name
- Navarro A
- type
- Author
- name
- Gottfried M
- type
- Author
- name
- Peters S
- type
- Author
- name
- Csőszi T
- type
- Author
- name
- Cheema PK
- type
- Author
- name
- Rodriguez-Abreu D
- type
- Author
- name
- Wollner M
- type
- Author
- name
- Yang JC
- type
- Author
- name
- Mazieres J
- type
- Author
- name
- Orlandi FJ
- type
- Author
- bibliography ids
- nci-bib-89dbef4c056d5743eb73ee35
- book metadata
- content sha256
- adbb61af281a2bc1db54a46e3cbfeedcb8bcda58efda5e4d926d30187a5ba390
- document type
- citation
- dois
- 10.1200/JCO.20.00793
- electronic publication date
- display
- 2020 May 29
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:32468956
- immutable id
- pubmed:32468956@adbb61af281a2bc1db54a46e3cbfeedcb8bcda58efda5e4d926d30187a5ba390
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 21
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2369-2379
- volume
- 38
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 32468956
- provenance
- batch id
- 40d9eae1f1d369f13109
- provider
- NCBI PubMed ESummary
- record sha256
- dd74374c8ee4b066277cdd51dc4456f03e2fdfb523ef1be56df812d86cd78dea
- response sha256
- 03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
- retrieved at
- 2026-09-09T23:47:52.637547+00:00
- publication date
- display
- 2020 Jul 20
- precision
- day
- year
- 2020
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study.
Preserved source evidence · Not medical advice